|
Volumn 10, Issue 7, 2001, Pages 659-662
|
Privacy issues in pharmacoepidemiology: The importance of weighing costs and benefits
|
Author keywords
Ethics; Medical data; Privacy; Record linkage; The Netherlands
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANTINEOPLASTIC AGENT;
LANSOPRAZOLE;
ORAL CONTRACEPTIVE AGENT;
ARTICLE;
AUTOMATION;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DATA BASE;
HUMAN;
INFORMED CONSENT;
JUSTICE;
MEDICAL ETHICS;
MEDICAL INFORMATION SYSTEM;
MEDICAL RECORD;
MEDICAL RESEARCH;
METHODOLOGY;
PHARMACOEPIDEMIOLOGY;
PRIORITY JOURNAL;
PRIVACY;
UNITED KINGDOM;
ACCESS TO INFORMATION;
BIOETHICS;
DATA COLLECTION;
DATABASES, FACTUAL;
HUMANS;
NETHERLANDS;
PHARMACOEPIDEMIOLOGY;
PRIVACY;
PUBLIC HEALTH;
RESEARCH;
|
EID: 0035570689
PISSN: 10538569
EISSN: None
Source Type: Journal
DOI: 10.1002/pds.645 Document Type: Article |
Times cited : (4)
|
References (17)
|